| 3. MANUFACTURING OPERATIONS - ACTIVE SUBSTANCES |
Active Substance:ADENOSINE, TESTED MICROBIOLOGICALLY AND FOR PYROGENES, CAS 58-61-7 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.3 Salt formation / Purification steps: crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, milling, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:ALFUZOSIN HYDROCHLORIDE, CAS 81403-68-1 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation, salt formation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:BRIMONIDINE TARTRATE, CAS 70359-46-5 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation, salt formation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:BROMFENAC SODIUM SESQUIHYDRATE, CAS 120638-55-3 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation, salt formation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:BUTAMIRATE CITRATE, CAS 18109-81-4 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation, salt formation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:DEFERASIROX, CAS 201530-41-8 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, milling, micronisation, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:DOFETILIDE, CAS 115256-11-6 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:DOXAZOSIN MESILATE, CAS 77883-43-3 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation, salt formation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:ENZALUTAMIDE, CAS 915087-33-1 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, milling/ micronization, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:ESZOPICLONE, CAS 138729-47-2 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation, salt formation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:HYMECROMONE, CAS 90-33-5 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation, salt formation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, milling, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:CHLORPROTHIXENE, CAS 113-59-7 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:CHLORPROTHIXENE HYDROCHLORIDE, CAS 6469-93-8 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation, salt formation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, milling, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:KETOROLAC TROMETAMOL, CAS 74103-07-4 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation, salt formation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:MEPHENOXALONE, CAS 70-07-5 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, milling, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:MOXONIDINE, CAS 75438-57-2 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, milling, micronisation, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:REGADENOSON, CAS 313348-27-5 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:REGADENOSONE MONOHYDRATE CAS 875148-45-1 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:RILUZOLE, CAS 1744-22-5 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying,milling, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:RIVAROXABAN, CAS 366789-02-8 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying,milling, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:SACUBITRIL SODIUM SALT, CAS 149690-05-1 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: salt formation, crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, milling, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:TIZANIDINE BASE CAS 51322-75-9 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:TIZANIDINE HYDROCHLORIDE, CAS 64461-82-1 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation, salt formation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, micronization, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:TREAMID (XC268BG) |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation, salt formation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:VALSARTAN DISODIUM SALT CAS 137862-53-4 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation, salt formation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:WARFARIN SODIUM AMORPHOUS, CAS 129-06-6 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation, salt formation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:WARFARIN SODIUM CLATHRATE, CAS 67430-45-9 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation, salt formation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, milling, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:XC-8, CAS 1464897-15-1 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation, salt formation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:ZOLPIDEM TARTRATE, CAS 99294-93-6 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation, salt formation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, milling, micronisation, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|
Active Substance:ZOPICLONE, CAS 43200-80-2 |
|
3.1
|
Manufacture of Active Substance by Chemical Synthesis
|
| |
| 3.1.1 Manufacture of active substance intermediates |
| 3.1.2 Manufacture of crude active substance |
| 3.1.3 Salt formation / Purification steps: crystallisation
|
|
|
3.5
|
General Finishing Steps
|
| |
| 3.5.1 Physical processing steps: drying, sieving
|
| 3.5.2 Primary Packaging (enclosing / sealing the active substance within a packaging material which is in direct contact with the substance) |
| 3.5.3 Secondary Packaging (placing the sealed primary package within an outer packaging material or container. This also includes any labelling of the material which could be used for identification or traceability (lot numbering) of the active substance) |
|
|
3.6
|
Quality Control Testing
|
| |
| 3.6.1 Physical / Chemical testing |
|